FINANCIAL GUIDANCE

Advertisement
Dec 04 2025HEALTH

A New Hope in Lung Cancer Treatment

Black Diamond Therapeutics has shared some promising news about their drug, silevertinib. It's being tested on people with a specific type of lung cancer. The results from the second phase of trials show that 60% of patients responded well to the treatment. This includes 25 partial responses and one

reading time less than a minute
Oct 24 2025BUSINESS

Rent Hikes and Market Shifts: What's Next for Equity LifeStyle?

Equity LifeStyle Properties has announced a 5. 1% rent increase for 2026, a move that reflects both internal strategies and external pressures. This decision comes as the company navigates through some tough market conditions, especially in Canada. The CEO, Marguerite Nader, pointed out that despite

reading time less than a minute
Jul 29 2025BUSINESS

Spotify's Stock Takes a Hit: What Went Wrong?

Spotify, the popular music streaming service, recently had a rough day on the stock market. The company's shares dropped over 11%, marking their worst performance since July 2023. The main issue? They didn't meet the financial goals set by Wall Street analysts. Let's break it down. Spotify's revenu

reading time less than a minute
May 29 2025BUSINESS

Tariffs Take a Toll: Best Buy's Financial Shift

Best Buy has recently announced a change in its financial outlook for the year. This change is largely due to increased tariffs, which have raised the costs of many products the company sells. These tariffs are part of a broader trade policy that has been causing waves in the U. S. economy. The comp

reading time less than a minute
May 28 2025FINANCE

Fashion Giant Faces Tariff Troubles but Sees Sales Surge

The fashion world is buzzing with news from Abercrombie & Fitch. Despite a gloomy forecast due to tariffs, the company's shares skyrocketed. This unexpected reaction came after the retailer announced a significant drop in its profit outlook. Tariffs, particularly a 30% hit on imports from China and

reading time less than a minute
Jan 14 2025BUSINESS

Why Eli Lilly's Weight-Loss Drug Sales Missed the Mark

Eli Lilly, a company based in Indianapolis, recently faced a blow when its stock prices dipped. The reason? Their weight-loss drugs, Zepbound and Mounjaro, didn't sell as well as expected. The company predicted they'd make about $13. 5 billion in the December quarter, which is less than what experts

reading time less than a minute
Oct 29 2024BUSINESS

Pfizer Posts Big Q3 Earnings, Raises Outlook

Pfizer, one of the world's largest pharmaceutical companies, surprised many analysts with its third-quarter earnings. The company reported earnings of $1. 06 per share, well above the expected $0. 61. Sales also exceeded expectations, coming in at $17. 7 billion compared to the projected $14. 92 bil

reading time less than a minute
Oct 09 2024BUSINESS

GM's Electric Push: A Bumpy Ride for Investors

General Motors (GM) held an investor day, but Wall Street seemed unimpressed. GM highlighted plans to boost profits for both electric and traditional vehicles. While GM believes it's ahead in the EV race, investors are waiting for more details. GM's CEO, Mary Barra, focused on efficiency and cost di

reading time less than a minute
Aug 27 2024TECHNOLOGY

Cognizant Technology's Future Outlook Shines After Belcan Acquisition

Cognizant Technology Solutions (NASDAQ:CTSH) has recently announced an update to its earnings guidance, reflecting the impact of its acquisition of Belcan, an engineering research and development services provider. The acquisition, which was completed for approximately $1.3B in cash and stock, has

reading time less than a minute